Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Hee Jeong Cho, Dong Won Baek, Juhyung Kim, Jung Min Lee, Joon Ho Moon & Sang Kyun Sohn. (2021) Keeping a balance in chronic lymphocytic leukemia (CLL) patients taking ibrutinib: ibrutinib-associated adverse events and their management based on drug interactions. Expert Review of Hematology 14:9, pages 819-830.
Read now
Read now
Iwona Hus, Aleksander Salomon-Perzyński, Krzysztof Tomasiewicz & Tadeusz Robak. (2021) The management of hematologic malignancies during the COVID-19 pandemic. Expert Opinion on Pharmacotherapy 22:5, pages 565-582.
Read now
Read now
Articles from other publishers (33)
Tamar Tadmor, Guy Melamed, Hillel Alapi, Sivan Gazit, Tal Patalon & Lior Rokach. (2023) Pregnancy Course of 10 Women Diagnosed with Chronic Lymphocytic Leukemia. Acta Haematologica, pages 1-5.
Crossref
Crossref
Iwona Hus, Agnieszka Szymczyk, Joanna Mańko & Joanna Drozd-Sokołowska. (2023) COVID-19 in Adult Patients with Hematological Malignancies—Lessons Learned after Three Years of Pandemic. Biology 12:4, pages 545.
Crossref
Crossref
Daniele Sorcini, Filomena De Falco, Marco Gargaro, Silvia Bozza, Valerio Guarente, Valeria Cardinali, Arianna Stella, Francesco Maria Adamo, Estevao Carlos Silva Barcelos, Chiara Rompietti, Erica Dorillo, Clelia Geraci, Angela Esposito, Roberta Arcaleni, Silvia Capoccia, Maria Grazia Mameli, Alessandro Graziani, Lorenzo Moretti, Alessandra Cipiciani, Carlo Riccardi, Antonella Mencacci, Francesca Fallarino, Emanuela Rosati & Paolo Sportoletti. (2022)
Immune correlates of protection by vaccine against
SARS‐CoV
‐2 in patients with chronic lymphocytic leukaemia
. British Journal of Haematology 201:1, pages 45-57.
Crossref
Crossref
Esra Turan Erkek & Eda Aslan. (2023) Additional malignancies shorten overall survival in chronic lymphocytic leukemia irrespective of chromosomal aberrations: A retrospective cohort study. Medicine 102:6, pages e32906.
Crossref
Crossref
Nina Shah, S. Shahzad Mustafa & Donald C. Vinh. (2023) Management of secondary immunodeficiency in hematological malignancies in the era of modern oncology. Critical Reviews in Oncology/Hematology 181, pages 103896.
Crossref
Crossref
Yusuke Ito, Akira Honda & Mineo Kurokawa. (2022) COVID-19 mRNA Vaccine in Patients With Lymphoid Malignancy or Anti-CD20 Antibody Therapy: A Systematic Review and Meta-Analysis. Clinical Lymphoma Myeloma and Leukemia 22:8, pages e691-e707.
Crossref
Crossref
Stefano Molica, Constantine Tam & Aaron Polliack. (2022) Current perspectives regarding SARS‐CoV‐2 vaccination in chronic lymphocytic leukemia. Hematological Oncology 40:3, pages 313-319.
Crossref
Crossref
Alexandre Nguyen, Nicolas Martin-Silva, Hubert De Boysson, Samuel Deshayes, Anne-Claire Gac, Emilie Reboursière, Gandhi Damaj & Achille Aouba. (2022) Low total gamma globulin level discovery at diffuse large B-cell lymphoma diagnosis predicts high risk of infection-related death: data from a monocentric retrospective study. Swiss Medical Weekly 152:2324, pages w30143.
Crossref
Crossref
Hartmut Link, Markus Kerkmann & Laura Holtmann. (2022) Immunoglobulin substitution in patients with secondary antibody deficiency in chronic lymphocytic leukemia and multiple myeloma: a representative analysis of guideline adherence and infections. Supportive Care in Cancer 30:6, pages 5187-5200.
Crossref
Crossref
Lauren J. Fried, Maressa C. Criscito, Mary L. Stevenson & Miriam K. Pomeranz. (2021) Chronic lymphocytic leukemia and the skin: implications for the dermatologist. International Journal of Dermatology 61:5, pages 519-531.
Crossref
Crossref
Maria Gavriatopoulou, Evangelos Terpos, Efstathios Kastritis, Alexandros Briasoulis, Sentiljana Gumeni, Ioannis Ntanasis-Stathopoulos, Aimilia D. Sklirou, Panagiotis Malandrakis, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, Ioannis P. Trougakos & Meletios A. Dimopoulos. (2021) Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine. Clinical and Experimental Medicine 22:2, pages 319-323.
Crossref
Crossref
Lorena Vigón, Adrián Sánchez-Tornero, Sara Rodríguez-Mora, Javier García-Pérez, Magdalena Corona de Lapuerta, Lucía Pérez-Lamas, Guiomar Casado-Fernández, Gemma Moreno, Montserrat Torres, Elena Mateos, María Aránzazu Murciano-Antón, José Alcamí, Mayte Pérez-Olmeda, Javier López-Jiménez, Valentín García-Gutiérrez & Mayte Coiras. (2022) Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection. Journal of Clinical Medicine 11:8, pages 2137.
Crossref
Crossref
Hadia Arzoun, Mirra Srinivasan, Stephanie Sandoval & Bridget Lee. (2022) A Systematic Review on the Prevention and Control of Opportunistic Infections in Patients With Chronic Lymphocytic Leukemia Complicated by Richter’s Transformation. Cureus.
Crossref
Crossref
Seema A. Bhat & Jennifer A. Woyach. (2022) Boosting BNT162b2 vaccine efficacy in CLL. Blood 139:5, pages 639-640.
Crossref
Crossref
Bartosz Puła, Katarzyna Pruszczyk, Ewa Pietrusza, Marta Morawska, Weronika Piszczek, Elżbieta Kalicińska, Agnieszka Szeremet, Jagoda Tryc-Szponder, Ewa Wąsik-Szczepanek, Joanna Drozd-Sokołowska, Helena Krzemień, Aleksandra Rejus, Małgorzata Gajewska, Kamil Wiśniewski, Maciej Wysocki, Alan Majeranowski, Ewa Paszkiewicz-Kozik, Paweł Steckiewicz, Łukasz Szukalski, Łukasz Bołkun, Monika Długosz-Danecka, Krzysztof Giannopoulos, Krzysztof Jamroziak, Ewa Lech-Marańda & Iwona Hus. (2022) Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia. Cancers 14:3, pages 558.
Crossref
Crossref
Stefano Molica, Diana Giannarelli, Mirella Lentini, Daniela Zappala, Ada Mannella, Daniela Loiacono, Valentina Gianfelici, Giuseppina Panduri, Iris Gariani, Pasquale Minchella, Francesco Talarico & Luciano Levato. (2022) Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia: A Serologic and Cellular Study. Chemotherapy 67:2, pages 91-95.
Crossref
Crossref
Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò, Georgios Karakatsoulis, David Allsup, Alejandro Alonso Cabrero, Martin Andres, Darko Antic, Mónica Baile, Panagiotis Baliakas, Dominique Bron, Antonella Capasso, Sofia Chatzileontiadou, Raul Cordoba, Juan-Gonzalo Correa, Carolina Cuéllar-García, Lorenzo De Paoli, Maria Rosaria De Paolis, Giovanni Del Poeta, Christos Demosthenous, Maria Dimou, David Donaldson, Michael Doubek, Maria Efstathopoulou, Barbara Eichhorst, Shaimaa El-Ashwah, Alicia Enrico, Blanca Espinet, Lucia Farina, Angela Ferrari, Myriam Foglietta, Henrik Frederiksen, Moritz Fürstenau, José A. García-Marco, Rocío García-Serra, Massimo Gentile, Eva Gimeno, Andreas Glenthøj, Maria Gomes da Silva, Odit Gutwein, Yervand K. Hakobyan, Yair Herishanu, José Ángel Hernández-Rivas, Tobias Herold, Idanna Innocenti, Gilad Itchaki, Ozren Jaksic, Ann Janssens, Оlga B. Kalashnikova, Elżbieta Kalicińska, Linda Katharina Karlsson, Arnon P. Kater, Sabina Kersting, Jorge Labrador, Deepesh Lad, Luca Laurenti, Mark-David Levin, Enrico Lista, Alberto Lopez-Garcia, Lara Malerba, Roberto Marasca, Monia Marchetti, Juan Marquet, Mattias Mattsson, Francesca R. Mauro, Ivana Milosevic, Fatima Mirás, Marta Morawska, Marina Motta, Talha Munir, Roberta Murru, Carsten U. Niemann, Raquel Nunes Rodrigues, Jacopo Olivieri, Lorella Orsucci, Maria Papaioannou, Miguel Arturo Pavlovsky, Inga Piskunova, Viola Maria Popov, Francesca Maria Quaglia, Giulia Quaresmini, Kristian Qvist, Gianluigi Reda, Gian Matteo Rigolin, Rosa Ruchlemer, Gevorg Saghumyan, Amit Shrestha, Martin Šimkovič, Martin Špaček, Paolo Sportoletti, Oana Stanca, Niki Stavroyianni, Tamar Tadmor, Doreen Te Raa, Sanne H. Tonino, Livio Trentin, Ellen Van Der Spek, Michel van Gelder, Roel van Kampen, Marzia Varettoni, Andrea Visentin, Candida Vitale, Ewa Wasik-Szczepanek, Tomasz Wróbel, Lucrecia Yáñez San Segundo, Mohamed Yassin, Marta Coscia, Alessandro Rambaldi, Emili Montserrat, Robin Foà, Antonio Cuneo, Kostas Stamatopoulos & Paolo Ghia. (2021) COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study. Leukemia 35:12, pages 3444-3454.
Crossref
Crossref
Maissa Mhibik, Erika M. GaglioneDavid Eik, Ellen K. Kendall, Amy BlackburnKeyvan KeyvanfarMaria Joao Baptista, Inhye E. AhnClare Sun, Junpeng Qi, Christoph Rader & Adrian Wiestner. (2021) BTK inhibitors, irrespective of ITK inhibition, increase efficacy of a CD19/CD3-bispecific antibody in CLL. Blood 138:19, pages 1843-1854.
Crossref
Crossref
Maria Gavriatopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Efstathios Kastritis, Ioannis P. Trougakos & Meletios A. Dimopoulos. (2021) Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study. Blood Advances 5:21, pages 4398-4405.
Crossref
Crossref
Gaby Judith Quispe Palomino, Naíza Arcângela Ribeiro de Sá, Denise Damasceno Guerreiro, Francisco Denilson Rodrigues Gomes, Renato Félix da Silva, Everton Pimentel Ferreira Lopes, Victor Macedo Paes, Pedro Henrique Silva Gataí, Benner Geraldo Alves, Otília Deusdênia Loiola Pessoa, José Ricardo Figueiredo, Rebeca Magalhães Pedrosa Rocha & Ana Paula Ribeiro Rodrigues. (2021) Induced-damages on preantral follicles by withanolide D, a potent chemotherapy candidate are not attenuated by melatonin. Reproductive Toxicology 104, pages 125-133.
Crossref
Crossref
Ohad Benjamini, Lior Rokach, Gilad Itchaki, Andrei Braester, Lev Shvidel, Neta Goldschmidt, Shirley Shapira, Najib Dally, Abraham Avigdor, Galia Rahav, Yaniv Lustig, Shirley Shapiro Ben David, Riva Fineman, Alona Paz, Osnat Bairey, Aaron Polliack, Ilana Levy & Tamar Tadmor. (2021) Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Haematologica 107:3, pages 625-634.
Crossref
Crossref
Thomas Chatzikonstantinou, Yair Herishanu, Emili Montserrat, Paolo Ghia, Antonio Cuneo, Robin Foà & Lydia Scarfò. (2021) COVID-19 and Chronic Lymphocytic Leukemia. The Cancer Journal 27:4, pages 328-333.
Crossref
Crossref
Yair Herishanu, Irit Avivi, Anat Aharon, Gabi SheferShai Levi, Yotam Bronstein, Miguel MoralesTomer Ziv, Yamit Shorer ArbelLydia Scarfò, Erel Joffe, Chava Perry & Paolo Ghia. (2021) Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood 137:23, pages 3165-3173.
Crossref
Crossref
Vilhjálmur Steingrímsson, Gauti Kjartan Gíslason, Sigrún Þorsteinsdóttir, Sæmundur Rögnvaldsson, Magnús Gottfreðsson, Thor Aspelund, Ingemar Turesson, Magnus Björkholm, Ola Landgren & Sigurdur Y. Kristinsson. (2020) A nationwide study on inpatient opportunistic infections in patients with chronic lymphocytic leukemia in the pre‐ibrutinib era. European Journal of Haematology 106:3, pages 346-353.
Crossref
Crossref
Tim Cooksley, Carme Font, Florian Scotte, Carmen Escalante, Leslie Johnson, Ronald Anderson & Bernardo Rapoport. (2020) Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper. Supportive Care in Cancer 29:2, pages 1129-1138.
Crossref
Crossref
Jun TakizawaKoji IzutsuHirokazu NagaiKenjiro FukaseMaki NakamuraMasahisa JinushiJunji Suzumiya. (2021) Real World Treatment Practices for Chronic Lymphocytic Leukemia in Japan: An Observational Database Research Study (CLIMBER-DBR). Journal of Clinical and Experimental Hematopathology 61:3, pages 126-134.
Crossref
Crossref
Shanmugapriya Thangavadivel, Qiuhong Zhao, Narendranath Epperla, Lindsey Rike, Xiaokui Mo, Mohamed Badawi, Darlene M. Bystry, Mitch A. Phelps, Leslie A. Andritsos, Kerry A. Rogers, Jeffrey Jones, Jennifer A. Woyach, John C. Byrd & Farrukh T. Awan. (2020) Early Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic Leukemia. Clinical Cancer Research 26:23, pages 6187-6195.
Crossref
Crossref
Vilhjálmur Steingrímsson, Gauti K. Gíslason, Thor Aspelund, Ingemar Turesson, Magnus Björkholm, Ola Landgren & Sigurdur Y. Kristinsson. (2020) A population‐based study on serious inpatient bacterial infections in patients with chronic lymphocytic leukemia and their impact on survival. European Journal of Haematology 105:5, pages 547-554.
Crossref
Crossref
Hans-Jürgen Laws, Ulrich Baumann, Christian Bogdan, Gerd Burchard, Maximilian Christopeit, Jane Hecht, Ulrich Heininger, Inken Hilgendorf, Winfried Kern, Kerstin Kling, Guido Kobbe, Wiebe Külper, Thomas Lehrnbecher, Roland Meisel, Arne Simon, Andrew Ullmann, Maike de Wit & Fred Zepp. (2020) Impfen bei Immundefizienz. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 63:5, pages 588-644.
Crossref
Crossref
Kevin Y. Chen, Kelly M. Brunk, Bianka A. Patel, Kurtis J. Stocker, Jessica J. Auten, Kaitlyn M. Buhlinger & Benyam Muluneh. (2020) Pharmacists’ Role in Managing Patients with Chronic Lymphocytic Leukemia. Pharmacy 8:2, pages 52.
Crossref
Crossref
Ali Sakhdari, Guilin Tang, Lawrence E. Ginsberg, Cheryl F. Hirsch-Ginsberg, Carlos E. Bueso-Ramos, L. Jeffrey Medeiros & Roberto N. Miranda. (2019) Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and T-Prolymphocytic Leukemia Presenting with Lymphocytosis, Skin Lesions, and Generalized Lymphadenopathy. Case Reports in Pathology 2019, pages 1-10.
Crossref
Crossref
Barbara Eichhorst, Michael Hallek & Valentin Goede. (2018) Management of unfit elderly patients with chronic lymphocytic leukemia. European Journal of Internal Medicine 58, pages 7-13.
Crossref
Crossref
Masuho SaburiMasao OgataKazuhito ItaniKazuhiro KohnoYasuhiro SogaYoshiyuki KondoYawara KawanoToshiyuki Nakayama. (2018) Rare concurrent indolent B-cell lymphoma and plasmablastic transformation of myeloma. Journal of Clinical and Experimental Hematopathology 58:4, pages 175-179.
Crossref
Crossref